Drug Profile
Research programme: melanocortin-4 receptor agonists - Amura
Latest Information Update: 06 Jul 2010
Price :
$50
*
At a glance
- Originator Amura
- Class
- Mechanism of Action Melanocortin type 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 07 Jun 2006 Preclinical trials in Obesity in United Kingdom (PO)